Literature DB >> 35930031

Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders.

Emanuel Boudriot1, Benedikt Schworm2, Christoph Kern2, Elias Wagner1, Florian J Raabe3,4, Lenka Slapakova1,5, Katharina Hanken1, Iris Jäger1, Marius Stephan1,5, Vanessa Gabriel1, Georgios Ioannou1, Julian Melcher1, Genc Hasanaj1, Mattia Campana1, Joanna Moussiopoulou1, Lisa Löhrs1, Alkomiet Hasan6, Peter Falkai1,7, Oliver Pogarell1, Siegfried Priglinger2, Daniel Keeser1,8,9.   

Abstract

BACKGROUND: Schizophrenia spectrum disorders (SSDs) are presumed to be associated with retinal thinning. However, evidence is lacking as to whether these retinal alterations reflect a disease-specific process or are rather a consequence of comorbid diseases or concomitant microvascular impairment.
METHODS: The study included 126 eyes of 65 patients with SSDs and 143 eyes of 72 healthy controls. We examined macula and optic disc measures by optical coherence tomography (OCT) and OCT angiography (OCT-A). Additive mixed models were used to assess the impact of SSDs on retinal thickness and perfusion and to explore the association of retinal and clinical disease-related parameters by controlling for several ocular and systemic covariates (age, sex, spherical equivalent, intraocular pressure, body mass index, diabetes, hypertension, smoking status, and OCT signal strength).
RESULTS: OCT revealed significantly lower parafoveal macular, macular ganglion cell-inner plexiform layer (GCIPL), and macular retinal nerve fiber layer (RNFL) thickness and thinner mean and superior peripapillary RNFL in SSDs. In contrast, the applied OCT-A investigations, which included macular and peripapillary perfusion density, macular vessel density, and size of the foveal avascular zone, did not reveal any significant between-group differences. Finally, a longer duration of illness and higher chlorpromazine equivalent doses were associated with lower parafoveal macular and macular RNFL thickness.
CONCLUSIONS: This study strengthens the evidence for disease-related retinal thinning in SSDs.
© 2022. The Author(s).

Entities:  

Keywords:  Angiography; OCT; Perfusion; Retina; Schizophrenia; Thickness

Year:  2022        PMID: 35930031     DOI: 10.1007/s00406-022-01455-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.760


  50 in total

Review 1.  Kraepelin revisited: schizophrenia from degeneration to failed regeneration.

Authors:  P Falkai; M J Rossner; T G Schulze; A Hasan; M M Brzózka; B Malchow; W G Honer; A Schmitt
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

Review 2.  The retina as a window to the brain-from eye research to CNS disorders.

Authors:  Anat London; Inbal Benhar; Michal Schwartz
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

3.  Specific Substantial Dysconnectivity in Schizophrenia: A Transdiagnostic Multimodal Meta-analysis of Resting-State Functional and Structural Magnetic Resonance Imaging Studies.

Authors:  Felix Brandl; Mihai Avram; Benedikt Weise; Jing Shang; Beatriz Simões; Teresa Bertram; Daniel Hoffmann Ayala; Nora Penzel; Deniz A Gürsel; Josef Bäuml; Afra M Wohlschläger; Zoran Vukadinovic; Nikolaos Koutsouleris; Stefan Leucht; Christian Sorg
Journal:  Biol Psychiatry       Date:  2018-12-11       Impact factor: 13.382

4.  White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs.

Authors:  Paul Klauser; Simon T Baker; Vanessa L Cropley; Chad Bousman; Alex Fornito; Luca Cocchi; Janice M Fullerton; Paul Rasser; Ulrich Schall; Frans Henskens; Patricia T Michie; Carmel Loughland; Stanley V Catts; Bryan Mowry; Thomas W Weickert; Cynthia Shannon Weickert; Vaughan Carr; Rhoshel Lenroot; Christos Pantelis; Andrew Zalesky
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

5.  Rethinking schizophrenia.

Authors:  Thomas R Insel
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

6.  Brain-Wide Analysis of Functional Connectivity in First-Episode and Chronic Stages of Schizophrenia.

Authors:  Tao Li; Qiang Wang; Jie Zhang; Edmund T Rolls; Wei Yang; Lena Palaniyappan; Lu Zhang; Wei Cheng; Ye Yao; Zhaowen Liu; Xiaohong Gong; Qiang Luo; Yanqing Tang; Timothy J Crow; Matthew R Broome; Ke Xu; Chunbo Li; Jijun Wang; Zhening Liu; Guangming Lu; Fei Wang; Jianfeng Feng
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

7.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects.

Authors:  Sander V Haijma; Neeltje Van Haren; Wiepke Cahn; P Cédric M P Koolschijn; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2012-10-05       Impact factor: 9.306

8.  Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.

Authors:  S Kelly; N Jahanshad; A Zalesky; P Kochunov; I Agartz; C Alloza; O A Andreassen; C Arango; N Banaj; S Bouix; C A Bousman; R M Brouwer; J Bruggemann; J Bustillo; W Cahn; V Calhoun; D Cannon; V Carr; S Catts; J Chen; J-X Chen; X Chen; C Chiapponi; Kl K Cho; V Ciullo; A S Corvin; B Crespo-Facorro; V Cropley; P De Rossi; C M Diaz-Caneja; E W Dickie; S Ehrlich; F-M Fan; J Faskowitz; H Fatouros-Bergman; L Flyckt; J M Ford; J-P Fouche; M Fukunaga; M Gill; D C Glahn; R Gollub; E D Goudzwaard; H Guo; R E Gur; R C Gur; T P Gurholt; R Hashimoto; S N Hatton; F A Henskens; D P Hibar; I B Hickie; L E Hong; J Horacek; F M Howells; H E Hulshoff Pol; C L Hyde; D Isaev; A Jablensky; P R Jansen; J Janssen; E G Jönsson; L A Jung; R S Kahn; Z Kikinis; K Liu; P Klauser; C Knöchel; M Kubicki; J Lagopoulos; C Langen; S Lawrie; R K Lenroot; K O Lim; C Lopez-Jaramillo; A Lyall; V Magnotta; R C W Mandl; D H Mathalon; R W McCarley; S McCarthy-Jones; C McDonald; S McEwen; A McIntosh; T Melicher; R I Mesholam-Gately; P T Michie; B Mowry; B A Mueller; D T Newell; P O'Donnell; V Oertel-Knöchel; L Oestreich; S A Paciga; C Pantelis; O Pasternak; G Pearlson; G R Pellicano; A Pereira; J Pineda Zapata; F Piras; S G Potkin; A Preda; P E Rasser; D R Roalf; R Roiz; A Roos; D Rotenberg; T D Satterthwaite; P Savadjiev; U Schall; R J Scott; M L Seal; L J Seidman; C Shannon Weickert; C D Whelan; M E Shenton; J S Kwon; G Spalletta; F Spaniel; E Sprooten; M Stäblein; D J Stein; S Sundram; Y Tan; S Tan; S Tang; H S Temmingh; L T Westlye; S Tønnesen; D Tordesillas-Gutierrez; N T Doan; J Vaidya; N E M van Haren; C D Vargas; D Vecchio; D Velakoulis; A Voineskos; J Q Voyvodic; Z Wang; P Wan; D Wei; T W Weickert; H Whalley; T White; T J Whitford; J D Wojcik; H Xiang; Z Xie; H Yamamori; F Yang; N Yao; G Zhang; J Zhao; T G M van Erp; J Turner; P M Thompson; G Donohoe
Journal:  Mol Psychiatry       Date:  2017-10-17       Impact factor: 15.992

9.  Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

Authors:  Theo G M van Erp; Esther Walton; Derrek P Hibar; Lianne Schmaal; Wenhao Jiang; David C Glahn; Godfrey D Pearlson; Nailin Yao; Masaki Fukunaga; Ryota Hashimoto; Naohiro Okada; Hidenaga Yamamori; Juan R Bustillo; Vincent P Clark; Ingrid Agartz; Bryon A Mueller; Wiepke Cahn; Sonja M C de Zwarte; Hilleke E Hulshoff Pol; René S Kahn; Roel A Ophoff; Neeltje E M van Haren; Ole A Andreassen; Anders M Dale; Nhat Trung Doan; Tiril P Gurholt; Cecilie B Hartberg; Unn K Haukvik; Kjetil N Jørgensen; Trine V Lagerberg; Ingrid Melle; Lars T Westlye; Oliver Gruber; Bernd Kraemer; Anja Richter; David Zilles; Vince D Calhoun; Benedicto Crespo-Facorro; Roberto Roiz-Santiañez; Diana Tordesillas-Gutiérrez; Carmel Loughland; Vaughan J Carr; Stanley Catts; Vanessa L Cropley; Janice M Fullerton; Melissa J Green; Frans A Henskens; Assen Jablensky; Rhoshel K Lenroot; Bryan J Mowry; Patricia T Michie; Christos Pantelis; Yann Quidé; Ulrich Schall; Rodney J Scott; Murray J Cairns; Marc Seal; Paul A Tooney; Paul E Rasser; Gavin Cooper; Cynthia Shannon Weickert; Thomas W Weickert; Derek W Morris; Elliot Hong; Peter Kochunov; Lauren M Beard; Raquel E Gur; Ruben C Gur; Theodore D Satterthwaite; Daniel H Wolf; Aysenil Belger; Gregory G Brown; Judith M Ford; Fabio Macciardi; Daniel H Mathalon; Daniel S O'Leary; Steven G Potkin; Adrian Preda; James Voyvodic; Kelvin O Lim; Sarah McEwen; Fude Yang; Yunlong Tan; Shuping Tan; Zhiren Wang; Fengmei Fan; Jingxu Chen; Hong Xiang; Shiyou Tang; Hua Guo; Ping Wan; Dong Wei; Henry J Bockholt; Stefan Ehrlich; Rick P F Wolthusen; Margaret D King; Jody M Shoemaker; Scott R Sponheim; Lieuwe De Haan; Laura Koenders; Marise W Machielsen; Therese van Amelsvoort; Dick J Veltman; Francesca Assogna; Nerisa Banaj; Pietro de Rossi; Mariangela Iorio; Fabrizio Piras; Gianfranco Spalletta; Peter J McKenna; Edith Pomarol-Clotet; Raymond Salvador; Aiden Corvin; Gary Donohoe; Sinead Kelly; Christopher D Whelan; Erin W Dickie; David Rotenberg; Aristotle N Voineskos; Simone Ciufolini; Joaquim Radua; Paola Dazzan; Robin Murray; Tiago Reis Marques; Andrew Simmons; Stefan Borgwardt; Laura Egloff; Fabienne Harrisberger; Anita Riecher-Rössler; Renata Smieskova; Kathryn I Alpert; Lei Wang; Erik G Jönsson; Sanne Koops; Iris E C Sommer; Alessandro Bertolino; Aurora Bonvino; Annabella Di Giorgio; Emma Neilson; Andrew R Mayer; Julia M Stephen; Jun Soo Kwon; Je-Yeon Yun; Dara M Cannon; Colm McDonald; Irina Lebedeva; Alexander S Tomyshev; Tolibjohn Akhadov; Vasily Kaleda; Helena Fatouros-Bergman; Lena Flyckt; Geraldo F Busatto; Pedro G P Rosa; Mauricio H Serpa; Marcus V Zanetti; Cyril Hoschl; Antonin Skoch; Filip Spaniel; David Tomecek; Saskia P Hagenaars; Andrew M McIntosh; Heather C Whalley; Stephen M Lawrie; Christian Knöchel; Viola Oertel-Knöchel; Michael Stäblein; Fleur M Howells; Dan J Stein; Henk S Temmingh; Anne Uhlmann; Carlos Lopez-Jaramillo; Danai Dima; Agnes McMahon; Joshua I Faskowitz; Boris A Gutman; Neda Jahanshad; Paul M Thompson; Jessica A Turner
Journal:  Biol Psychiatry       Date:  2018-05-14       Impact factor: 12.810

10.  Anatomical and functional changes in the retina in patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Stephan Szegedi; Peter Dal-Bianco; Elisabeth Stögmann; Tatjana Traub-Weidinger; Michael Rainer; Andreas Masching; Doreen Schmidl; René M Werkmeister; Jacqueline Chua; Leopold Schmetterer; Gerhard Garhöfer
Journal:  Acta Ophthalmol       Date:  2020-03-25       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.